Axel Schörling
Vermogen: 1 M $ op 31-08-2026
Vermogen: 1 M $ op 31-08-2026
Axel Schörling is President & Chief Executive Officer at EQL Pharma AB since 2022 and Independent Director at Gasporox AB since 2023.
Formerly, Mr. Schörling was Director-Business Controlling at Perstorp AB. Mr. Schörling graduated from Chalmers University of Technology and Handelshögskolan i Göteborg.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EQL PHARMA AB 1,36% | 27-03-2026 | 401.445 ( 1,36% ) | 1 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EQL PHARMA AB | Algemeen Directeur | 17-08-2022 |
| GASPOROX AB | Directeur/Bestuurslid | 01-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PERSTORP HOLDING AB (PUBL.) | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Perstorp AB
Perstorp AB Chemicals: SpecialtyProcess Industries Manufactures and supplies specialty chemicals | Process Industries |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gasporox AB
Gasporox AB Miscellaneous Commercial ServicesCommercial Services Provides laser technology and aims to benefits from non-intrusive diode laser spectroscopy technology | Commercial Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau